Clinical Trials Browser

Phase 1 × Not yet recruiting × Lymphoma, B-Cell × Clear all

NCT07532525 2026-04-16

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

NCT07101328 2026-03-20

BAF_FRontier-1

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT07451054 2026-03-05

CD45BE-HSPC + CART-45 Cells

Phase 1 Not yet recruiting

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07367685 2026-01-26

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT07334574 2026-01-13

XP-006

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT07335328 2026-01-13

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT07316920 2026-01-06

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Phase 1 Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT07166549 2025-12-24

BaseCAR-01

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06970496 2025-11-20

A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.

Phase 1 Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT07234045 2025-11-18

A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

Phase 1 Not yet recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07068906 2025-07-16

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT07032324 2025-06-23

CT1190B

Phase 1 Not yet recruiting

Lymphoma, B-Cell

NCT07024147 2025-06-17

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

Phase 1 Not yet recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06894693 2025-03-25

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06314828 2024-03-18

A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL

Phase 1 Not yet recruiting

Lymphoma, B-Cell